Market Forecast By Product Types (Anti-Inflammatory Drugs, Vaccines, Antibiotics, Animal Feed Additives, Parasiticides, Skin Care Products, Others), By Distribution Channel And Competitive Landscape
Product Code: ETC044725 | Publication Date: Jun 2023 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Iraq Companion Animal Specialty drugs market is expected to grow at a CAGR of 6.4% during the forecast period 2020-2026. The increasing demand for pet care, growing awareness among pet owners about animal health and wellness, growing elderly population, rising disposable income levels of consumers, and increasing trend of adopting pets are some major factors driving the growth of this market in Iraq. Furthermore, the rise in zoonotic diseases is likely to create opportunities for market players operating in the companion animal speciality drugs industry.
Major companies operating in this industry include Zoetis Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Merck & Co., Bayer AG, Virbac Corporation (VIRBAC SA), Novartis AG (Sandoz International GmbH), Dechra Pharmaceuticals PLC (Dechra Veterinary Products USA LLC), Elanco Animal Health Incorporated (Eli Lilly and Company) and others. These companies are investing heavily in R&D activities to develop new products as well as strengthen their presence across developing countries such as Iraq.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iraq Companion Animal Specialty Drugs Market Overview |
3.1 Iraq Country Macro Economic Indicators |
3.2 Iraq Companion Animal Specialty Drugs Market Revenues & Volume, 2019 & 2026F |
3.3 Iraq Companion Animal Specialty Drugs Market - Industry Life Cycle |
3.4 Iraq Companion Animal Specialty Drugs Market - Porter's Five Forces |
3.5 Iraq Companion Animal Specialty Drugs Market Revenues & Volume Share, By Product Types, 2019 & 2026F |
3.6 Iraq Companion Animal Specialty Drugs Market Revenues & Volume Share, By Distribution Channel, 2019 & 2026F |
4 Iraq Companion Animal Specialty Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Iraq Companion Animal Specialty Drugs Market Trends |
6 Iraq Companion Animal Specialty Drugs Market, By Types |
6.1 Iraq Companion Animal Specialty Drugs Market, By Product Types |
6.1.1 Overview and Analysis |
6.1.2 Iraq Companion Animal Specialty Drugs Market Revenues & Volume, By Product Types, 2016 - 2026F |
6.1.3 Iraq Companion Animal Specialty Drugs Market Revenues & Volume, By Anti-Inflammatory Drugs, 2016 - 2026F |
6.1.4 Iraq Companion Animal Specialty Drugs Market Revenues & Volume, By Vaccines, 2016 - 2026F |
6.1.5 Iraq Companion Animal Specialty Drugs Market Revenues & Volume, By Antibiotics, 2016 - 2026F |
6.1.6 Iraq Companion Animal Specialty Drugs Market Revenues & Volume, By Animal Feed Additives, 2016 - 2026F |
6.1.7 Iraq Companion Animal Specialty Drugs Market Revenues & Volume, By Parasiticides, 2016 - 2026F |
6.1.8 Iraq Companion Animal Specialty Drugs Market Revenues & Volume, By Skin Care Products, 2016 - 2026F |
6.2 Iraq Companion Animal Specialty Drugs Market, By Distribution Channel |
6.2.1 Overview and Analysis |
7 Iraq Companion Animal Specialty Drugs Market Import-Export Trade Statistics |
7.1 Iraq Companion Animal Specialty Drugs Market Export to Major Countries |
7.2 Iraq Companion Animal Specialty Drugs Market Imports from Major Countries |
8 Iraq Companion Animal Specialty Drugs Market Key Performance Indicators |
9 Iraq Companion Animal Specialty Drugs Market - Opportunity Assessment |
9.1 Iraq Companion Animal Specialty Drugs Market Opportunity Assessment, By Product Types, 2019 & 2026F |
9.2 Iraq Companion Animal Specialty Drugs Market Opportunity Assessment, By Distribution Channel, 2019 & 2026F |
10 Iraq Companion Animal Specialty Drugs Market - Competitive Landscape |
10.1 Iraq Companion Animal Specialty Drugs Market Revenue Share, By Companies, 2019 |
10.2 Iraq Companion Animal Specialty Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |